News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
3 million Wegovy pills filled as GLP-1 obesity drug expands
Novo Nordisk reports 3 million Wegovy oral prescriptions filled, with one dispensed every 5 seconds. The company presented new data at ADA 2026 on reaching previously untreated patients.
Oncopeptides enrolls first patient in German real-world multiple myeloma study
Oncopeptides has started its Marina study across 25 German clinical sites to track Pepaxti's performance in routine multiple myeloma care. The 50-patient trial will measure outcomes beyond controlled trials.
Survodutide cuts visceral fat 34%, liver fat 63% in phase 3 obesity trial
Boehringer Ingelheim's dual glucagon/GLP-1 agonist achieved up to 16.6% weight loss in 76-week trial, with separate analysis showing metabolic benefits beyond the scale.
EU approves IntraBio's Aqneursa for rare neurological disease NPC
The European Commission granted marketing authorisation for levacetylleucine to treat Niemann-Pick disease type C in patients aged six and above. Phase III data showed 118% reduction in annual disease progression.
Sanofi Licenses Owkin AI Platform for Drug Discovery Agents
Sanofi extends its five-year partnership with Owkin to deploy custom agentic AI tools across drug development. The move builds on a €90m collaboration launched in 2021 focused on oncology and immunology pipelines.
Seven biotech giants spent $15B+ in May on rare disease, vaccines, and ADCs
Angelini paid $4.1B for Catalyst, Lilly bought three vaccine makers, and BMS licensed 13 oncology programs from Hengrui for $15.2B. Here's what each deal targets.
Abivax UC Drug Rebounds After Cancer Scare, Analyst Splits on Label Risk
Abivax shares plunged 44% then recovered 40% as four Wall Street firms weighed nine malignancy cases against strong efficacy data. The real question: how many analysts will stick around if a black box warning lands?
Three biotech obesity plays face acquisition pressure as weight loss drugs race heats up
Lilly, Viking, and Kailera are emerging takeover targets as larger pharma companies move to consolidate obesity treatment pipelines. Here's what to watch in the consolidation wave.
India's Hospitals Grow Revenue 18% as Bed Expansions Squeeze Margins
Listed Indian hospitals posted 18% YoY sales growth in Q4 FY26, but new bed additions kept EBITDA margins flat. Mature units still earned 25.5% margins — here's who won and who stumbled.
NTA denies NEET exam paper leak, warns of fraud charges
India's National Testing Agency dismissed social media claims of a leaked or sold NEET-UG 2026 re-exam paper, calling them false and aimed at exploiting student anxiety. The retest is scheduled for June 21.
India delays anaemia data from health survey, swaps blood test method
NFHS-6 excluded haemoglobin testing due to concerns over capillary sampling. New venous-blood survey from ICMR expected to fill gap with more accurate results.
Two Ebola suspects in Hyderabad test negative; thermal screening catches fever cases
Telangana set up a 10-bed isolation ward at Gandhi Hospital after two Sudanese nationals tested negative for Ebola. Airport thermal screening and intake protocols caught both cases before spread.